Antibodies Against Human Cd39 And Use Thereof

Patent No. EP2654789 (titled "Antibodies Against Human Cd39 And Use Thereof") was filed by Inserm Institut National DE LA Sant ET DE LA Recherche Mdicale on Dec 21, 2011. The application was issued on May 30, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOULT WADE TENNANTFeb 28, 2019BOULT WADE TENNANT
D YOUNGFeb 28, 2019HOIBERG PS
TIZONA THERAPEUTICSFeb 26, 2019HUTTER
ABBVIEFeb 15, 2019MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2654789

INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE
Application Number
EP11801741A
Filing Date
Dec 21, 2011
Status
Revoked
Sep 6, 2024
Publication Date
May 30, 2018